Stem Cell Niches in Bone and Their Roles in Cancer Metastasis
Published in Advances in Stem Cells and their Niches (Elsevier), 2022
The bone marrow is comprised of a diverse array of cell types, including those of mesenchymal origin (e.g., osteoblasts, osteocytes, and adipocytes), those of hematopoietic origin (e.g., immune cells and osteoclasts), endothelial cells and nerve cells. It has long been appreciated that the niche microenvironments formed by these cells are not only the sites of residence of their normal stem cell precursors, but are also the primary sites of metastasis for cancers which spread to bone, such as breast and prostate. At present there is no curative treatment for bone metastasis; approximately 75,000 deaths occur annually in the U.S.A. due to metastatic breast and prostate cancer. It is ultimately the reciprocal cross talk between metastatic cancer cells arriving in the bone and the cells that form their supporting microenvironmental niches that determines the course of pathological progression and hence patient outcome. In this chapter we discuss the cellular constituents of the various physiological niche microenvironments that cancer cells interact with to form the metastatic niche in bone, as well as describe the most well defined molecular mechanisms that are currently proposed to govern the pathogenesis of bone metastasis. Further unraveling and understanding these mechanisms and the biological interplay between DTCs and the components of the niche microenvironment in which they reside will be critical in order to improve the prognostic outlook for patients with bone metastases.
